JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
Centrify Named to JMP Securities Fast 50 List of Hottest Privately Held Security and Networking Companies
-
JMP Securities Upgrades D.R. Horton (DHI) to Market Outperform
-
JMP Securities Upgrades KB Home (KBH) to Market Outperform
-
JMP Securities Upgrades Ryland Group (RYL) to Market Outperform
-
BioLineRx (BLRX) Prices 12.5M Public Offering at $2/ADS
-
BioLineRx Prices $25 Million Underwritten Public Offering of its American Depositary Shares
-
Horizon Pharma plc Prices Offering of $350 Million of 2.50% Exchangeable Senior Notes
-
Intra-Cellular Therapies (ITCI) Prices 4.75M Offering at $24/Share
-
Intra-Cellular Therapies Prices $114 Million Public Offering of Common Stock
-
Intra-Cellular Therapies Prices $114 Million Public Offering of Common Stock
-
BioLineRx (BLRX) Announces ADS Offering
-
BioLineRx Announces Underwritten Public Offering of its American Depositary Shares
-
Summit Therapeutics (SMMT) IPO Opens Fractionally Higher
-
Apollo Commercial Real Estate Finance (ARI) Prices 10M Common Offering for Proceeds of $170M
-
Apollo Commercial Real Estate Finance, Inc. Announces Pricing of Public Offering of Common Stock
-
Summit Therapeutics Announces Pricing of U.S. Initial Public Offering and Nasdaq Global Market Listing
-
Apollo Commercial Real Estate Finance (ARI) Announces 10M Common Offering
-
Northstar Realty Finance (NRF) Prices 60M Common Offering at $18.65/Share
-
JMP Securities Starts Nexvet Biopharma (NVET) at Market Outperform
-
JMP Securities Upgrades Silver Bay Realty Trust Corp. (SBY) to Market Outperform
-
Actua Executives Invited to Participate at Upcoming Investor Conferences
-
JMP Securities Starts Pandora (P) at Market Perform
-
Varonis to Present at Upcoming March Conferences
-
TrueCar Announces Upcoming March Conference Participation
-
JMP Securities Starts Newtek Business Services (NEWT) at Market Perform
-
Notable Analyst Rating Changes 2/23: (LH) (PENN) (CL) Upgraded; (BA) (RIG) (DGX) Downgraded
-
JMP Securities Starts Flex Pharma (FLKS) at Market Outperform
-
Notable Analyst Rating Changes 2/19: (COH) (VLO) (MWW) Upgraded; (I) (PCYC) (HUN) Downgraded
-
JMP Securities Starts TubeMogul, Inc (TUBE) at Market Outperform
-
JMP Securities Downgrades Vascular Biogenics Ltd (VBLT) to Market Perform
-
Ultragenyx Announces Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Triangle Capital Corporation Closes Overallotment Option in Connection With Public Offering of 6.375% Notes Due 2022 and Trading of Notes Begins on NYSE
-
Achillion Pharma (ACHN) 12M Offering Prices at $10.25/Share
-
JMP Securities Downgrades AOL, Inc. (AOL) to Market Perform
-
Nexvet Biopharma (NVET) Closes 4M Common IPO at $4/Share
-
Nexvet Biopharma Announces Closing of Initial Public Offering
-
Intercept Pharmaceuticals Announces Completion of Public Offering and Exercise of Option to Purchase Additional Shares
-
JMP Securities Starts Patriot National (PN) at Market Outperform
-
JMP Securities Downgrades Chesapeake Lodging Trust (CHSP) to Market Perform
-
Nexvet Biopharma (NVET) IPO Opens Down 9%
-
BIND Therapeutics (BIND) Prices 3.7M Offering at $5.75/Unit
-
JMP Securities Downgrades PartnerRe (PRE) to Market Perform
-
Ultragenyx Pharmaceutical (RARE) 3M Offering Prices at $54/Share
-
Intercept Pharma (ICPT) 1M Stock Offering Prices at $176/Share
-
Nexvet Biopharma plc Announces Pricing of Initial Public Offering
-
Intercept Pharmaceuticals Announces Pricing of Public Offering
-
BIND Therapeutics (BIND) to Offer Common Stock and Warrants
-
BIND Therapeutics (BIND) Announces Common Stock Offering
-
Senior Housing Properties Trust (SNH) Prices 27M Share Offering at $22.20/Share
-
JMP Securities Upgrades Myriad Genetics (MYGN) to Market Outperform

